Alzamend Neuro Inc (ALZN)

Jan 26, 2026

Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Jan 26, 2026

Jan 25, 2026

Is Community Health Systems Incs ROE strong enough2025 Biggest Moves & Real-Time Market Sentiment Reports - baoquankhu1.vn

Jan 25, 2026

Jan 19, 2026

Is Alzamend Neuro Inc. stock heavily shortedWeekly Profit Analysis & Daily Profit Maximizing Tips - bollywoodhelpline.com

Jan 19, 2026

Jan 17, 2026

Aug Sectors: Is Alzamend Neuro Inc stock heavily shortedJuly 2025 News Drivers & Weekly High Return Opportunities - baoquankhu1.vn

Jan 17, 2026

Jan 13, 2026

Bond Watch: Can Alzamend Neuro Inc stock beat market expectations this quarterQuarterly Growth Report & Capital Protection Trade Alerts - Bộ Nội Vụ

Jan 13, 2026

Jan 13, 2026

Alzamend Neuro (NASDAQ:ALZN) Stock Price Down 2.5% – Should You Sell? - Defense World

Jan 13, 2026

Jan 10, 2026

Can Alzamend Neuro Inc. stock beat analyst upgradesJuly 2025 Outlook & Safe Entry Point Identification - ulpravda.ru

Jan 10, 2026

Jan 09, 2026

ContactThe Lethbridge HeraldNews and Sports from around Lethbridge - FinancialContent

Jan 09, 2026

Jan 09, 2026

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Jan 09, 2026

Jan 08, 2026

Will Alzamend Neuro Inc. stock attract ESG investorsJuly 2025 Outlook & Precise Swing Trade Entry Alerts - Улправда

Jan 08, 2026

Jan 08, 2026

Will Alzamend Neuro Inc. stock return to pre crisis levelsJuly 2025 Short Interest & Safe Entry Zone Tips - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

What technical charts say about Alzamend Neuro Inc. stockQuarterly Performance Summary & Reliable Price Breakout Alerts - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Is AIM ImmunoTech (AIM) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Jan 08, 2026

Jan 06, 2026

Alzamend Neuro, Inc.Common Stock (NQ: ALZN - FinancialContent

Jan 06, 2026

Dec 31, 2025

Momentum Shift: Will Alzamend Neuro Inc stock attract ESG investorsEarnings Performance Report & Stepwise Trade Signal Implementation - Bộ Nội Vụ

Dec 31, 2025

Dec 25, 2025

Ascendiant Sticks to Their Buy Rating for Alzamend Neuro (ALZN) - The Globe and Mail

Dec 25, 2025

Dec 22, 2025

Ascendiant Capital Maintains Alzamend Neuro (ALZN) Buy Recommendation - Nasdaq

Dec 22, 2025

Dec 22, 2025

ALZN: Ascendiant Capital Lowers Price Target, Maintains Buy Rati - GuruFocus

Dec 22, 2025

Dec 20, 2025

Decliners Report: Why Alzamend Neuro Inc. stock is recommended by analystsQuarterly Market Review & Detailed Earnings Play Strategies - Улправда

Dec 20, 2025

Dec 19, 2025

Will Alzamend Neuro Inc. stock deliver long term returnsWeekly Profit Analysis & Consistent Profit Trade Alerts - Улправда

Dec 19, 2025

Dec 19, 2025

Is Alzamend Neuro Inc. stock attractive for ETFs2025 Support & Resistance & Community Verified Trade Signals - Улправда

Dec 19, 2025

Dec 19, 2025

Can Alzamend Neuro Inc. stock maintain growth trajectoryWeekly Trade Analysis & Risk Managed Trade Strategies - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Alzamend Neuro Earnings Notes - Trefis

Dec 19, 2025

Dec 18, 2025

Why Alzamend Neuro Inc. stock is recommended by analystsQuarterly Growth Report & Verified Momentum Watchlists - Улправда

Dec 18, 2025

Dec 18, 2025

Can Alzamend Neuro Inc. stock sustain market leadershipJuly 2025 Chart Watch & Consistent Return Investment Signals - Улправда

Dec 18, 2025

Dec 09, 2025

Alzamend Neuro, Inc. SEC 10-Q Report - TradingView

Dec 09, 2025

Dec 06, 2025

Is Alzamend Neuro Inc stock attractive for passive investorsWeekly Investment Summary & Weekly Top Gainers Alerts - BỘ NỘI VỤ

Dec 06, 2025

Dec 04, 2025

Why Alzamend Neuro Inc. stock remains undervaluedJuly 2025 Analyst Calls & High Accuracy Trade Alerts - Newser

Dec 04, 2025

Dec 01, 2025

Alzamend Neuro (ALZN) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025

Nov 29, 2025

Alzamend Neuro Mourns Loss of Director Andrew Woo - MSN

Nov 29, 2025

Nov 27, 2025

Is Alzamend Neuro Inc. stock attractive for passive investors2025 Earnings Impact & Daily Profit Focused Stock Screening - BỘ NỘI VỤ

Nov 27, 2025

Nov 26, 2025

Alzamend Neuro: Will Topline Data Spark Investor Interest? - RTTNews

Nov 26, 2025

Nov 25, 2025

Alzamend Neuro's AL001 formulation highlights its potential to treat disorders such a Alzheimer's - SelectScience

Nov 25, 2025

Nov 21, 2025

What margin trends mean for Alzamend Neuro Inc. stockWeekly Market Outlook & Verified Swing Trading Watchlists - newser.com

Nov 21, 2025

Nov 21, 2025

Why Alzamend Neuro Inc. stock could see breakout soonProduct Launch & High Return Trade Opportunity Guides - newser.com

Nov 21, 2025

Nov 20, 2025

Why Alzamend Neuro Inc. stock could benefit from AI revolutionTrade Risk Report & Daily Profit Maximizing Tips - newser.com

Nov 20, 2025

Nov 20, 2025

Can Alzamend Neuro Inc. stock sustain revenue growthMarket Risk Analysis & Pattern Based Trade Signal System - newser.com

Nov 20, 2025

Nov 19, 2025

Will Alzamend Neuro Inc. stock rally after Fed decisionsJuly 2025 Closing Moves & Safe Swing Trade Setup Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Will Alzamend Neuro Inc. stock reach all time highs in 2025Exit Point & Daily Technical Forecast Reports - newser.com

Nov 19, 2025

Nov 19, 2025

Alzamend completes clinical portion of phase II trial for lithium therapy - Investing.com Nigeria

Nov 19, 2025

Nov 19, 2025

Published on: 2025-11-19 13:20:00 - newser.com

Nov 19, 2025

Nov 19, 2025

Alzamend Neuro announces passing of board member Andrew H. Woo By Investing.com - Investing.com Australia

Nov 19, 2025

Nov 19, 2025

Comparing Alzamend Neuro Inc. in custom built stock radarsWeekly Risk Summary & Weekly Momentum Picks - newser.com

Nov 19, 2025

Nov 19, 2025

Alzamend Neuro announces completion of clinical portion of phase II clinical trial of AL001 "lithium in brain" study conducted at Massachusetts General Hospital - MarketScreener

Nov 19, 2025

Nov 19, 2025

Alzamend rises after completing mid-stage brain lithium study - TradingView

Nov 19, 2025

Nov 19, 2025

Alzamend Neuro (Nasdaq: ALZN) completes AL001 Phase II trial; 2026 lithium imaging data - Stock Titan

Nov 19, 2025

Nov 19, 2025

EXCLUSIVE: Alzamend Wraps Clinical Phase Of AL001 Study In Healthy Participants - Benzinga

Nov 19, 2025